US Patent 9512221 Anti-TLR4 antibodies and methods of use thereof
Patent 9512221 was granted and assigned to Novimmune on December, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9512221 Anti-TLR4 antibodies and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.